GMP細胞バンキングサービスの世界市場：細胞タイプ別、エンドユーザー別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

希少疾患の研究開発に対する資金提供の増加は、予測期間中に世界のGMP細胞バンクサービス市場の成長を後押しすると予想されます。さらに、発展途上国におけるバイオテクノロジー分野の急速な拡大や、バイオテクノロジー産業の振興に向けた政府の取り組みも、予測期間中の市場成長を促進すると予想されます。

当レポートでは、世界のGMP細胞バンキングサービス市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査目的・前提条件

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
  • 市場の内訳：細胞タイプ別
  • 市場の内訳：エンドユーザー別
  • 市場の内訳：地域別
  • コヒーレントオポチュニティマップ（COM）

第3章 市場力学、規制、および動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 影響分析
• 主なハイライト
• 製品発売
• PEST分析
• 規制シナリオ
• 合併と買収

第4章 世界のGMP細胞バンキングサービス市場：細胞タイプ別（100万米ドル）（2017年～2028年）

• イントロダクション
• 哺乳類
• 微生物
• 昆虫
• 酵母
• 鳥類
• 幹細胞
• その他

第5章 世界のGMP細胞バンキングサービス市場：エンドユーザー別（100万米ドル）（2017年～2028年）

• イントロダクション
• バイオ製薬企業
• 受託製造機関

第6章 世界のGMP細胞バンキングサービス市場：地域別（100万米ドル）（2017年～2028年）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第7章 競合情勢

• 企業プロファイル
  • WuXi AppTec Group
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Merck KGaA
  • Lonza Group Ltd.
  • SGS Ltd.
  • ViruSure GmbH
  • Austrianova
  • Goodwin Biotechnology Inc.
  • Paragon Bioservices, Inc.

第8章 セクション

GMP cell banking services is termed as the storing of cells of specific genome for the purpose of future use in a product or medicinal needs. Different types of cell lines stored in cell banks constitute of mammalian cells, microbial cells, insect cell lines, yeast cells, avian cells, and stem cells. Increasing funding for R&D in rare diseases is expected to boost growth of the global GMP cell banking services market over the forecast period. Furthermore, rapidly increasing biotechnology sector in developing countries along with increased government initiatives to promote biotechnology industry is also expected to propel the growth of the market during the forecast period.

Key features of the study:

This report provides in-depth analysis of the GMP Cell Banking Services market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players

It profiles key players in the global GMP Cell Banking Services market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include, WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global GMP Cell Banking Services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP Cell Banking Services market

Detailed Segmentation:

GMP Cell Banking Services Market, By Cell Type:

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

GMP Cell Banking Services Market, By End User:

Biopharmaceutical Companies

Contract Manufacturing Organizations

GMP Cell Banking Services Market, By Region:

North America

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

U.S.

Canada

Latin America

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

GCC

Israel

Rest of Middle East

Africa

By Cell Type

Mammalian

Microbial

Insect

Yeast

Avian

Stem Cell Type

Others

By End User

Biopharmaceutical Companies

Contract Manufacturing Organizations

By Country:

South Africa

Central Africa

North Africa

Company Profiles

WuXi AppTec Group *

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Charles River Laboratories International, Inc.

Eurofins Scientific

Merck KGaA

Lonza Group Ltd.

SGS Ltd.

ViruSure GmbH

Austrianova

Goodwin Biotechnology Inc.

Paragon Bioservices, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Cell Type
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product launch
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global GMP Cell Banking Services Market, By Cell Type, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Microbial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Insect
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Yeast
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Avian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Stem Cell Type
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global GMP Cell Banking Services Market, By End User, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Contract Manufacturing Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global GMP Cell Banking Services Market, By Region, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of APAC
• Middle East
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Cell Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

7. Competitive Landscape

• Company Profiles
  • WuXi AppTec Group
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Charles River Laboratories International, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Eurofins Scientific
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Merck KGaA
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Lonza Group Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • SGS Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • ViruSure GmbH
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Austrianova
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Goodwin Biotechnology Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Paragon Bioservices, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies

8. Section

• References
• Research Methodology
• About us and Sales Contact